Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Psychopharmacology and Psychiatry Updates · Psychopharmacology Institute
June 30, 202510m 7s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking?
Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.